688617 Stock Overview
Engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 6/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
APT Medical Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥365.03 |
| 52 Week High | CN¥480.00 |
| 52 Week Low | CN¥213.81 |
| Beta | -0.35 |
| 11 Month Change | 0.30% |
| 3 Month Change | 2.42% |
| 1 Year Change | 52.96% |
| 33 Year Change | 72.41% |
| 5 Year Change | n/a |
| Change since IPO | 105.93% |
Recent News & Updates
Recent updates
Shareholders Would Enjoy A Repeat Of APT Medical's (SHSE:688617) Recent Growth In Returns
Oct 16
Should You Be Adding APT Medical (SHSE:688617) To Your Watchlist Today?
Sep 19More Unpleasant Surprises Could Be In Store For APT Medical Inc.'s (SHSE:688617) Shares After Tumbling 27%
Jul 25APT Medical (SHSE:688617) Is Very Good At Capital Allocation
Jul 16Are APT Medical Inc. (SHSE:688617) Investors Paying Above The Intrinsic Value?
Jun 20APT Medical Inc. (SHSE:688617) Stock Rockets 28% As Investors Are Less Pessimistic Than Expected
May 10APT Medical's (SHSE:688617) Promising Earnings May Rest On Soft Foundations
May 02APT Medical (SHSE:688617) Knows How To Allocate Capital Effectively
Apr 10Here's Why We Think APT Medical (SHSE:688617) Might Deserve Your Attention Today
Mar 19Shareholder Returns
| 688617 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | 7.7% | -2.4% | -3.4% |
| 1Y | 53.0% | -5.5% | 6.1% |
Return vs Industry: 688617 exceeded the CN Medical Equipment industry which returned -5.5% over the past year.
Return vs Market: 688617 exceeded the CN Market which returned 6.1% over the past year.
Price Volatility
| 688617 volatility | |
|---|---|
| 688617 Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.2% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.5% |
Stable Share Price: 688617 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688617's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 2,422 | Zhenghui Cheng | www.aptmed.com |
APT Medical Inc. engages in the research, development, manufacturing, and supply of electrophysiology and vascular interventional medical devices in China. The company offers electrophysiological products comprising mapping catheters, ablation catheters, transseptal needle and sheaths, and steerable sheaths; and interventional cardiology and peripheral intervention products, such as introducer kits, guiding extension catheters, balloon catheters, guiding catheters, microcatheters, guidewires, hydrophilic angiographic catheters, hydrophilic guidewires, hemostatsis introducers, radial compression devices, aspiration catheters, inflation devices, Y connectors, snare kits, hemostasis valves, L guiding sheaths, balloon occlusion microcatheters, embolic protection device, transjugular liver access sets, and steerable guiding sheaths. It also provides OEM/ODM services, including project design and development, customization, and volume OEM, etc. APT Medical Inc. was founded in 2002 and is headquartered in Shenzhen, China.
APT Medical Inc. Fundamentals Summary
| 688617 fundamental statistics | |
|---|---|
| Market cap | CN¥35.39b |
| Earnings (TTM) | CN¥658.82m |
| Revenue (TTM) | CN¥1.96b |
53.7x
P/E Ratio18.0x
P/S RatioIs 688617 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688617 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.96b |
| Cost of Revenue | CN¥555.18m |
| Gross Profit | CN¥1.41b |
| Other Expenses | CN¥747.33m |
| Earnings | CN¥658.82m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 27, 2024
| Earnings per share (EPS) | 6.80 |
| Gross Margin | 71.69% |
| Net Profit Margin | 33.59% |
| Debt/Equity Ratio | 0.3% |
How did 688617 perform over the long term?
See historical performance and comparison